
The Oregon Psilocybin Advisory Board held its second-to-last meeting with Oregon Health Authority officials and attorneys from the Department of Justice (DOJ), prior to sending final recommendations to state regulators.
The meeting was apparently contentious, and for the first time, it began with a closed-door executive session. Journalists were permitted to attend if they vowed not to report on it, yet the public was excluded, wrote Mason Marks on Marijuana Moment.